{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T12:23:10Z","timestamp":1756902190852,"version":"3.44.0"},"reference-count":33,"publisher":"The Pediatric Pharmacy Association","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"abstract":"<jats:p>We report on a former 28-week gestation neonate with persistent methicillin-resistant <jats:italic>Staphylococcus aureus<\/jats:italic> (MRSA) endocarditis, with a heterozygous Factor V Leiden mutation. The neonate became clinically ill after 1 week of life, with positive blood cultures for MRSA. Echocardiography revealed large thrombi in the inferior vena cava and right atrium. Bacteremia persisted despite removal of umbilical arterial and venous catheters and empiric administration of therapeutic doses of vancomycin (minimum inhibitory concentration [MIC] 2 mg\/L) and ceftazidime. To narrow therapy, ceftazidime was discontinued, while gentamicin and rifampin were added. Cultures remained positive and, therefore, linezolid was added, and subsequent blood cultures became negative. Since prolonged linezolid use of 2 weeks or longer carries potential adverse effects, antibiotics were changed to daptomycin, which is bactericidal and recommended for treatment of invasive MRSA infections when vancomycin MICs are \u22652 mg\/L to minimize vancomycin treatment failure.<\/jats:p>\n        <jats:p>Enoxaparin was initiated, with anti-Xa assay monitoring. A workup for thrombophilia revealed heterozygous Factor V Leiden mutation. Serial echocardiograms demonstrated decreasing size of the thrombi, which were no longer visualized at 2 months of age. Creatinine kinase remained normal. The infant had no seizures on daptomycin. The management of persistent MRSA bacteremia in neonates associated with a large thrombus poses a unique challenge due to the long duration of treatment.<\/jats:p>\n        <jats:p>To our knowledge, this is the first case of prolonged and safe daptomycin and enoxaparin use in a preterm neonate. Daptomycin may be considered in cases of clinical failure with vancomycin when a lengthy treatment course is contemplated.<\/jats:p>","DOI":"10.5863\/1551-6776-25.1.68","type":"journal-article","created":{"date-parts":[[2019,12,30]],"date-time":"2019-12-30T20:44:18Z","timestamp":1577738658000},"page":"68-74","source":"Crossref","is-referenced-by-count":0,"title":["Methicillin-Resistant Staphylococcus aureus Endovascular Infection in a Neonate: Prolonged, Safe, and Effective Use of Daptomycin and Enoxaparin"],"prefix":"10.5863","volume":"25","author":[{"given":"Joshua I.","family":"Chan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asif","family":"Noor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christie","family":"Clauss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renu","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amrita","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3883","reference":[{"issue":"12","key":"i1551-6776-25-1-68-b1","series-title":"Paediatr Drugs","first-page":"883","article-title":"Management of preterm infants with intracardiac thrombi: use of thrombolytic agents","volume":"3","year":"2001","unstructured":"Rimensberger\n              PC\n            , HumbertJR, BeghettiM.\n          Management of preterm infants with intracardiac thrombi: use of thrombolytic agents. Paediatr Drugs. 2001;3(12):883\u2013898."},{"issue":"3","key":"i1551-6776-25-1-68-b2","series-title":"Intensive Care Med","first-page":"466","article-title":"Infectious complications of percutaneous central venous catheterization in pediatric patients: a Spanish multicenter study","volume":"33","year":"2007","unstructured":"Garc\u00eda-Teresa\n              MA\n            , Casado-FloresJ, Delgado Dom\u00ednguezMA, \n          et al. Infectious complications of percutaneous central venous catheterization in pediatric patients: a Spanish multicenter study. Intensive Care Med. 2007;33(3):466\u2013476."},{"key":"i1551-6776-25-1-68-b3","series-title":"Cochrane Database Syst Rev","article-title":"Heparin for the treatment of thrombosis in neonates","volume":"11","year":"2016","unstructured":"Romantsik\n              O\n            , BruschettiniM, ZappettiniS, \n          et al. Heparin for the treatment of thrombosis in neonates. Cochrane Database Syst Rev. 2016;11:CD012185. doi:10.1002\/14651858.CD012185.pub2."},{"issue":"5","key":"i1551-6776-25-1-68-b4","series-title":"Clin Appl Thromb Hemost","first-page":"488","article-title":"Evaluation of the use of low-molecular-weight heparin in neonates: a retrospective, single-center study","volume":"19","year":"2013","unstructured":"Chander\n              A\n            , NagelK, WiernikowskiJ, \n          et al. Evaluation of the use of low-molecular-weight heparin in neonates: a retrospective, single-center study. Clin Appl Thromb Hemost. 2013;19(5):488\u2013493."},{"issue":"1","key":"i1551-6776-25-1-68-b5","series-title":"Arch Dis Child Fetal Neonatal Ed","first-page":"66","article-title":"Early intracardiac thrombosis in preterm infants and thrombolysis with recombinant tissue type plasminogen activator","volume":"85","year":"2001","unstructured":"Ferrari\n              F\n            , VagnarelliF, GarganoG, \n          et al. Early intracardiac thrombosis in preterm infants and thrombolysis with recombinant tissue type plasminogen activator. Arch Dis Child Fetal Neonatal Ed. 2001;85(1):66. doi:10.1136\/fn.85.1.f66."},{"key":"i1551-6776-25-1-68-b6","series-title":"Infect Drug Resist","first-page":"9","article-title":"Successful treatment of a neonate with persistent vancomycin-resistant enterococcal bacteremia with a daptomycin-containing regimen","volume":"1","year":"2008","unstructured":"Beneri\n              CA\n            , NicolauDP, SeidenHS, RubinLG.\n          Successful treatment of a neonate with persistent vancomycin-resistant enterococcal bacteremia with a daptomycin-containing regimen. Infect Drug Resist. 2008;1:9\u201311."},{"issue":"5","key":"i1551-6776-25-1-68-b7","series-title":"Pediatrics","first-page":"1039","article-title":"Emergence of and risk factors for methicillin-resistant Staphylococcus aureus of community origin in intensive care nurseries","volume":"122","year":"2008","unstructured":"Seybold\n              U\n            , HalvosaJS, WhiteN, \n          et al. Emergence of and risk factors for methicillin-resistant Staphylococcus aureus of community origin in intensive care nurseries. Pediatrics. 2008;122(5):1039\u20131046."},{"issue":"3","key":"i1551-6776-25-1-68-b8","series-title":"Clin Infect Dis","first-page":"285","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary","volume":"52","year":"2011","unstructured":"Liu\n              C\n            , BayerA, CosgroveSE, \n          et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis. 2011;52(3):285\u2013292."},{"year":"2014","series-title":"Cubicin package insert","key":"i1551-6776-25-1-68-b9","unstructured":"Cubist Pharmaceuticals US. \n          Cubicin package insert. Lexington, MA; 2014. http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2003\/21-572_Cubicin.cfm."},{"issue":"1","key":"i1551-6776-25-1-68-b10","series-title":"J Pediatr Pharmacol Ther","first-page":"61","article-title":"Successful use of daptomycin in a preterm neonate with persistent methicillin-resistant Staphylococcus epidermidis bacteremia","volume":"20","year":"2015","unstructured":"Gawronski\n              KM.\n            \n          \n          Successful use of daptomycin in a preterm neonate with persistent methicillin-resistant Staphylococcus epidermidis bacteremia. J Pediatr Pharmacol Ther. 2015;20(1):61\u201365."},{"issue":"3","key":"i1551-6776-25-1-68-b11","series-title":"J Perinatol","first-page":"233","article-title":"Daptomycin use in infants: report of two cases with peak and trough drug concentrations","volume":"28","year":"2008","unstructured":"Cohen-Wolkowiez\n              M\n            , SmithPB, BenjaminDK, \n          et al. Daptomycin use in infants: report of two cases with peak and trough drug concentrations. J Perinatol. 2008;28(3):233\u2013234."},{"issue":"4","key":"i1551-6776-25-1-68-b12","series-title":"Infection","first-page":"367","article-title":"Serum levels of daptomycin in pediatric patients","volume":"40","year":"2012","unstructured":"Antachopoulos\n              C\n            , IosifidisE, SarafidisK, \n          et al. Serum levels of daptomycin in pediatric patients. Infection. 2012;40(4):367\u2013371."},{"issue":"5","key":"i1551-6776-25-1-68-b13","series-title":"Arch Argent Pediatr","first-page":"470","article-title":"Linezolid-related adverse effects in clinical practice in children","volume":"115","year":"2017","unstructured":"Bayram\n              N\n            , D\u00fczg\u00f6lM, KaraA, \n          et al. Linezolid-related adverse effects in clinical practice in children. Arch Argent Pediatr. 2017;115(5):470\u2013475."},{"issue":"2","key":"i1551-6776-25-1-68-b14","series-title":"Pediatr Infect Dis J","first-page":"169","article-title":"Auditory nerve neuropathy in a neonate after linezolid treatment","volume":"28","year":"2009","unstructured":"Brennan\n              K\n            , JonesBL, JacksonL.\n          Auditory nerve neuropathy in a neonate after linezolid treatment. Pediatr Infect Dis J. 2009;28(2):169. doi:10.1097\/INF.0b013e31818fd8f5."},{"series-title":"Daptomycin. Lexicomp Online, Pediatric and Neonatal Lexi-Drugs Online","key":"i1551-6776-25-1-68-b15","unstructured":"Daptomycin. Lexicomp Online, Pediatric and Neonatal Lexi-Drugs Online. Hudson, OH: Wolters Kluwer Clinical Drug Information Inc. https:\/\/online.lexi.com\/lco\/action\/doc\/retrieve\/docid\/pdh_f\/128599?searchUrl=%2Flco%2Faction%2Fsearch%3Fq%3Ddaptomycin%26t%3Dname%26va%3Ddaptomycin. Updated 2018. Accessed January 20, 2018."},{"year":"2017","series-title":"Nelson's Pediatric Antimicrobial Therapy","key":"i1551-6776-25-1-68-b16","unstructured":"Bradley\n              JS\n            , NelsonJD, BarnettE, \n          et al. Nelson's Pediatric Antimicrobial Therapy. 23rd ed. (Itasca, IL) American Academy of Pediatrics; 2017."},{"issue":"5","key":"i1551-6776-25-1-68-b17","series-title":"Am J Perinatol","first-page":"421","article-title":"Daptomycin use in a neonate: serum level monitoring and outcome","volume":"27","year":"2010","unstructured":"Sarafidis\n              K\n            , IosifidisE, GikasE, \n          et al. Daptomycin use in a neonate: serum level monitoring and outcome. Am J Perinatol. 2010;27(5):421\u2013424."},{"year":"2018","series-title":"Enoxaparin. Lexicomp Online, Pediatric and Neonatal Lexi-Drugs Online","key":"i1551-6776-25-1-68-b18","unstructured":"Enoxaparin. Lexicomp Online, Pediatric and Neonatal Lexi-Drugs Online, Hudson, OH: Wolters Kluwer Clinical Drug Information Inc; 2018. https:\/\/online-lexi-com.winthrop.idm.oclc.org\/lco\/action\/doc\/retrieve\/docid\/pdh_f\/129858. Accessed January 28, 2018."},{"issue":"1","key":"i1551-6776-25-1-68-b19","series-title":"Am J Infect Control","first-page":"35","article-title":"Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus colonization and infection among infants at a level III neonatal intensive care unit","volume":"39","year":"2011","unstructured":"Maraqa\n              NF\n            , AigbivbaluL, Masnita-IusanC, \n          et al. Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus colonization and infection among infants at a level III neonatal intensive care unit. Am J Infect Control. 2011;39(1):35\u201341."},{"issue":"2","key":"i1551-6776-25-1-68-b20","series-title":"Pediatrics","first-page":"469","article-title":"Methicillin-resistant Staphylococcus aureus colonization and its association with infection among infants hospitalized in neonatal intensive care units","volume":"118","year":"2006","unstructured":"Huang\n              Y\n            , ChouY, SuL, \n          et al. Methicillin-resistant Staphylococcus aureus colonization and its association with infection among infants hospitalized in neonatal intensive care units. Pediatrics. 2006;118(2):469\u2013474."},{"issue":"6","key":"i1551-6776-25-1-68-b21","series-title":"Infect Control Hosp Epidemiol","first-page":"613","article-title":"Changes in the molecular epidemiological characteristics of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit","volume":"31","year":"2010","unstructured":"Carey\n              AJ\n            , Della-LattaP, HuardR, \n          et al. Changes in the molecular epidemiological characteristics of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Infect Control Hosp Epidemiol. 2010;31(6):613\u2013619."},{"issue":"4","key":"i1551-6776-25-1-68-b22","series-title":"Pediatrics","first-page":"e1015","article-title":"MRSA colonization and risk of infection in the neonatal and pediatric ICU: a meta-analysis","volume":"133","year":"2014","unstructured":"Zervou\n              FN\n            , ZacharioudakisIM, ZiakasPD, MylonakisE.\n          MRSA colonization and risk of infection in the neonatal and pediatric ICU: a meta-analysis. Pediatrics. 2014;133(4):e1015\u2013e1023."},{"issue":"10","key":"i1551-6776-25-1-68-b23","series-title":"Arch Dis Child","first-page":"781","article-title":"Enhanced surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in children in the UK and Ireland","volume":"95","year":"2010","unstructured":"Johnson\n              AP\n            , SharlandM, GoodallCM, \n          et al. Enhanced surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in children in the UK and Ireland. Arch Dis Child. 2010;95(10):781\u2013785."},{"issue":"1","key":"i1551-6776-25-1-68-b24","series-title":"Pharmacotherapy","first-page":"105","article-title":"Clinical experience with daptomycin in pediatrics","volume":"37","year":"2017","unstructured":"Namtu\n              KC\n            , CrainJC, MessinaAF, \n          et al. Clinical experience with daptomycin in pediatrics. Pharmacotherapy. 2017;37(1):105\u2013108. doi:10.1002\/phar.1872."},{"key":"i1551-6776-25-1-68-b25","unstructured":"Lexicomp Online, Pediatric and Neonatal. Daptomycin Pediatric Drug information. UpToDate; 2018. https:\/\/www.uptodate.com\/contents\/daptomycin-pediatric-drug-information?search=daptomycin%20children&source=search_result&selectedTitle=1~64&usage_type=default&display_rank=1. Accessed January 15, 2018.","article-title":"Lexicomp Online, Pediatric and Neonatal. Daptomycin Pediatric Drug information. UpToDate; 2018"},{"issue":"10","key":"i1551-6776-25-1-68-b26","series-title":"Pediatr Infect Dis J","first-page":"962","article-title":"Daptomycin use in children: experience with various types of infection and age groups","volume":"36","year":"2017","unstructured":"Syrogiannopoulos\n              GA\n            , MichoulaAN, PetinakiE, GriveaIN.\n          Daptomycin use in children: experience with various types of infection and age groups. Pediatr Infect Dis J. 2017;36(10):962\u2013966."},{"issue":"Pt 3","key":"i1551-6776-25-1-68-b27","series-title":"J Med Microbiol","first-page":"381","article-title":"Successful treatment of methicillin-resistant Staphylococcus aureus bacteraemia in a neonate using daptomycin","volume":"60","year":"2011","unstructured":"Hussain\n              A\n            , KairamkondaV, JenkinsDR.\n          Successful treatment of methicillin-resistant Staphylococcus aureus bacteraemia in a neonate using daptomycin. J Med Microbiol. 2011;60(Pt 3):381\u2013383."},{"issue":"6","key":"i1551-6776-25-1-68-b28","series-title":"Pediatr Infect Dis J","first-page":"639","article-title":"Daptomycin for children in clinical practice experience","volume":"35","year":"2016","unstructured":"Garazzino\n              S\n            , CastagnolaE, Di GangiM, \n          et al. Daptomycin for children in clinical practice experience. Pediatr Infect Dis J. 2016;35(6):639\u2013641."},{"issue":"9","key":"i1551-6776-25-1-68-b29","series-title":"Pediatr Infect Dis J","first-page":"935","article-title":"Pharmacokinetics and tolerability of single-dose daptomycin in young infants","volume":"31","year":"2012","unstructured":"Cohen-Wolkowiez\n              M\n            , WattKM, HornikCP, \n          et al. Pharmacokinetics and tolerability of single-dose daptomycin in young infants. Pediatr Infect Dis J. 2012;31(9):935\u2013937."},{"issue":"7","key":"i1551-6776-25-1-68-b30","series-title":"Blood","first-page":"1073","article-title":"Manifestations and clinical impact of pediatric inherited thrombophilia","volume":"125","year":"2015","unstructured":"Klaassen\n              ILM\n            , van OmmenCH, MiddeldorpS.\n          Manifestations and clinical impact of pediatric inherited thrombophilia. Blood. 2015;125(7):1073\u20131077."},{"issue":"2 Suppl","key":"i1551-6776-25-1-68-b31","series-title":"Chest","first-page":"e801S","article-title":"Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","year":"2012","unstructured":"Monagle\n              P\n            , ChanAKC, GoldenbergNA, \n          et al. Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 Suppl):e801S. doi:10.1378\/chest.11-2308."},{"issue":"11","key":"i1551-6776-25-1-68-b32","series-title":"Pediatr Blood Cancer","article-title":"Association of outcomes and anti-Xa levels in the treatment of pediatric venous thromboembolism","volume":"64","year":"2017","unstructured":"Fan\n              JL\n            , RobertsLE, ScheurerME, \n          et al. Association of outcomes and anti-Xa levels in the treatment of pediatric venous thromboembolism. Pediatr Blood Cancer. 2017;64(11). doi:10.1002\/pbc.26629."},{"issue":"3","key":"i1551-6776-25-1-68-b33","series-title":"Pediatrics","first-page":"703","article-title":"Low molecular weight heparin in the treatment of venous and arterial thromboses in the premature infant","volume":"114","year":"2004","unstructured":"Michaels\n              LA\n            , GurianM, HegyiT, DrachtmanRA.\n          Low molecular weight heparin in the treatment of venous and arterial thromboses in the premature infant. Pediatrics. 2004;114(3):703\u2013707."}],"container-title":["The Journal of Pediatric Pharmacology and Therapeutics"],"original-title":[],"link":[{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/25\/1\/article-p68.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/jppt\/article-pdf\/25\/1\/68\/2466937\/1551-6776-25_1_68.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/25\/1\/article-p68.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/25\/1\/article-p68.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:38:24Z","timestamp":1747355904000},"score":1,"resource":{"primary":{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/25\/1\/article-p68.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":33,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.5863\/1551-6776-25.1.68","relation":{},"ISSN":["1551-6776"],"issn-type":[{"type":"print","value":"1551-6776"}],"subject":[],"published":{"date-parts":[[2020]]}}}